For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Sernivo | Betamethasone Dipropionate Spray and its risk associated with lactation. We will also discuss the usage of Sernivo | Betamethasone Dipropionate Spray and some common side effects associated with Sernivo | Betamethasone Dipropionate Spray.
What is Sernivo | Betamethasone Dipropionate Spray used for?
SERNIVO Spray is indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. SERNIVO Spray is a corticosteroid indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older. (1)
I am currently breastfeeding and I want to know if using Sernivo | Betamethasone Dipropionate Spray is safe for my kid? Does it have any effect on milk production?
Sernivo | Betamethasone Dipropionate Spray contains only one active ingredient that is Betamethasone. We have analyzed the usage of Betamethasone in breastfeeding and our analysis suggest that Betamethasone poses Low risk for infant while breastfeeding and hence Sernivo | Betamethasone Dipropionate Spray itself shall be considered Low risk item for breastfeeding.
Statement of Manufacturer/Labeler about breastfeeding usage
8.3 Nursing Mothers Systemically administered corticosteroids appear in human milk and can suppress growth, interfere with endogenous corticosteroid production, or cause other untoward effects. It is not known whether topical administration of corticosteroids can result in sufficient systemic absorption to produce detectable quantities in human milk. Because many drugs are excreted in human milk, caution should be exercised when SERNIVO Spray is administered to a nursing woman.
Sernivo | Betamethasone Dipropionate Spray Breastfeeding Analsys
Betamethasone while Breastfeeding Low Risk
CAS Number: 378-44-9
Because pharmacokinetic data suggest excretion into breast milk in significant levels long lasting treatments should use other steroidal drugs known to be excreted in low amounts. When administered before delivery it may induce delay in phase II of Lactogenesis (coming-in) and a decrease of milk production within the first week post-partum. Large intra-articular doses may transitory decrease milk production. WHO Model List of Essential Drugs 2002: Compatible with breastfeeding.
Sernivo | Betamethasone Dipropionate Spray Breastfeeding Analsys - 2
Betamethasone while Breastfeeding
CAS Number: 378-44-9
Betamethasone has not been well studied during breastfeeding after systemic or topical use. Systemic betamethasone is best avoided in favor of one of the shorter-acting and better studied alternatives because of its potency and low protein binding which would favor its passage into milk. Use of betamethasone 3 to 9 days prior to delivery of a preterm infant might decrease postpartum milk production in some women. Local injections, such as for tendinitis, would not be expected to cause any adverse effects in breastfed infants, but might occasionally cause temporary loss of milk supply.
What should I do if I am breastfeeding mother and I am already exposed to Sernivo | Betamethasone Dipropionate Spray?
During whole lactation period you shall first discuss with your doctor and then together you shall decide whether you shall take that drug or not however if you have already taken Sernivo | Betamethasone Dipropionate Spray then you shall inform your doctor, But you should not be worried too much as Sernivo | Betamethasone Dipropionate Spray comes in category of low risk drug.
My health care provider has asked me to use Sernivo | Betamethasone Dipropionate Spray, what to do?
Though Sernivo | Betamethasone Dipropionate Spray dose not comes in category of safe drugs rather it comes in category of low risk but if your doctor is aware that you are breastfeeding your baby and has still recommended it then its advantages must be outweighing the risks.
If I am using Sernivo | Betamethasone Dipropionate Spray, will my baby need extra monitoring?
Who can I talk to if I have questions about usage of Sernivo | Betamethasone Dipropionate Spray in breastfeeding?
National Womens Health and Breastfeeding Helpline: 800-994-9662 (TDD 888-220-5446) 9 a.m. and 6 p.m. ET, Monday through Friday
National Breastfeeding Helpline: 0300-100-0212 9.30am to 9.30pm, daily
Association of Breastfeeding Mothers: 0300-330-5453
La Leche League: 0345-120-2918
The Breastfeeding Network supporter line in Bengali and Sylheti: 0300-456-2421
National Childbirth Trust (NCT): 0300-330-0700
National Breastfeeding Helpline: 1800-686-268 24 hours a day, 7 days a week
Telehealth Ontario for breastfeeding: 1-866-797-0000 24 hours a day, 7 days a week